Aspiriant LLC’s Schwab US Large- Cap ETF SCHX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.98M Sell
194,382
-33,018
-15% -$886K 0.14% 70
2025
Q4
$6.12M Sell
227,400
-2,519
-1% -$67.3K 0.18% 63
2025
Q3
$6.06M Sell
229,919
-491
-0.2% -$12.5K 0.19% 57
2025
Q2
$5.63M Sell
230,410
-1,352
-0.6% -$30.6K 0.18% 57
2025
Q1
$5.12M Sell
231,762
-23,152
-9% -$539K 0.18% 55
2024
Q4
$5.91M Sell
254,914
-2,072
-0.8% -$48.3K 0.21% 52
2024
Q3
$5.81M Buy
256,986
+2,658
+1% +$57.9K 0.22% 50
2024
Q2
$5.45M Hold
254,328
0.22% 53
2024
Q1
$5.26M Sell
254,328
-4,896
-2% -$96.4K 0.22% 55
2023
Q4
$4.87M Buy
259,224
+1,719
+0.7% +$30.2K 0.22% 55
2023
Q3
$4.34M Buy
257,505
+2,145
+0.8% +$37.6K 0.22% 56
2023
Q2
$4.46M Sell
255,360
-8,631
-3% -$143K 0.23% 55
2023
Q1
$4.26M Buy
263,991
+924
+0.4% +$14.5K 0.22% 55
2022
Q4
$3.96M Sell
263,067
-13,329
-5% -$202K 0.2% 59
2022
Q3
$3.9M Sell
276,396
-3,726
-1% -$58.5K 0.19% 54
2022
Q2
$4.17M Sell
280,122
-4,941
-2% -$80.1K 0.2% 57
2022
Q1
$5.12M Sell
285,063
-20,745
-7% -$367K 0.28% 49
2021
Q4
$5.8M Buy
305,808
+36,948
+14% +$683K 0.31% 42
2021
Q3
$4.66M Sell
268,860
-1,302
-0.5% -$23.2K 0.27% 46
2021
Q2
$4.68M Sell
270,162
-12,576
-4% -$212K 0.26% 41
2021
Q1
$4.52M Sell
282,738
-11,118
-4% -$174K 0.29% 36
2020
Q4
$4.46M Sell
293,856
-402
-0.1% -$5.75K 0.3% 36
2020
Q3
$3.95M Sell
294,258
-1,698
-0.6% -$22.6K 0.31% 41
2020
Q2
$3.66M Sell
295,956
-76,278
-20% -$889K 0.34% 38
2020
Q1
$3.8M Sell
372,234
-16,296
-4% -$198K 0.37% 37
2019
Q4
$4.98M Buy
388,530
+17,892
+5% +$219K 0.46% 34
2019
Q3
$4.38M Buy
370,638
+4,698
+1% +$55.4K 0.39% 41
2019
Q2
$4.28M Sell
365,940
-37,566
-9% -$432K 0.36% 46
2019
Q1
$4.55M Sell
403,506
-17,508
-4% -$190K 0.37% 47
2018
Q4
$4.19M Sell
421,014
-10,830
-3% -$116K 0.32% 51
2018
Q3
$5M Sell
431,844
-117,372
-21% -$1.33M 0.43% 44
2018
Q2
$5.95M Sell
549,216
-59,868
-10% -$646K 0.51% 39
2018
Q1
$6.4M Buy
609,084
+542,088
+809% +$5.9M 0.56% 36
2017
Q4
$712K Sell
66,996
-860,562
-93% -$8.91M 0.21% 42
2017
Q3
$9.28M Sell
927,558
-255,606
-22% -$2.51M 0.78% 29
2017
Q2
$11.4M Sell
1,183,164
-117,918
-9% -$1.12M 0.99% 24
2017
Q1
$12.2M Sell
1,301,082
-6,060
-0.5% -$56K 1.04% 24
2016
Q4
$11.6M Sell
1,307,142
-1,488
-0.1% -$12.9K 1.05% 20
2016
Q3
$11.3M Buy
1,308,630
+209,712
+19% +$1.8M 1.12% 16
2016
Q2
$9.03M Sell
1,098,918
-406,356
-27% -$3.34M 0.85% 16
2016
Q1
$12.3M Buy
+1,505,274
New +$11.6M 1.17% 14
2015
Q4
Sell
-30,900
Closed -$245K 87
2015
Q3
$245K Buy
30,900
+72
+0.2% +$582 0.02% 94
2015
Q2
$253K Buy
+30,828
New +$259K 0.02% 98

Other funds holding SCHX

Aspiriant LLC's SCHX Position: Q1 2026 in Review

Aspiriant LLC reduced its Schwab US Large- Cap ETF (SCHX) stake by 15% in Q1 2026, selling an estimated $886K and leaving 194,382 shares worth $4.98M. The position accounts for 0.14% of the portfolio, ranked #70.

Aspiriant LLC first reported a position in SCHX in Q2 2015 and has held it in 43 quarters since. The position peaked at $12.3M in Q1 2016. 1,534 funds tracked by Wall St. Rank hold SCHX as of Q1 2026.

  • Aspiriant LLC held 194,382 shares of Schwab US Large- Cap ETF worth $4.98M as of Q1 2026.
  • Aspiriant LLC sold 33,018 Schwab US Large- Cap ETF shares in Q1 2026, an estimated $886K.
  • Schwab US Large- Cap ETF made up 0.14% of Aspiriant LLC's portfolio in Q1 2026, its #70 holding.
  • Aspiriant LLC first reported a position in Schwab US Large- Cap ETF in Q2 2015 and has held it in 43 quarters since.
  • Aspiriant LLC's Schwab US Large- Cap ETF position peaked at $12.3M in Q1 2016.
  • 1,534 funds tracked by Wall St. Rank held Schwab US Large- Cap ETF as of Q1 2026.

Based on Aspiriant LLC's 13F filing for Q1 2026, filed 12 May 2026.